{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:48:26Z","timestamp":1772833706132,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.brainres.2025.149444","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T19:50:36Z","timestamp":1735847436000},"page":"149444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A non-purine inhibitor of xanthine oxidoreductase mitigates adenosine triphosphate degradation under hypoxic conditions in mouse brain"],"prefix":"10.1016","volume":"1849","author":[{"given":"Nana","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2025.149444_b0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/bja\/47.2.121","article-title":"Hypoxic brain damage","volume":"47","author":"Adams","year":"1975","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.brainres.2025.149444_b0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1042\/bj0970318","article-title":"The species distribution of xanthine oxidase","volume":"97","author":"Al-Khalidi","year":"1965","journal-title":"Biochem. J."},{"key":"10.1016\/j.brainres.2025.149444_b0015","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1021\/bi00851a033","article-title":"The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers","volume":"7","author":"Atkinson","year":"1968","journal-title":"Biochemistry"},{"key":"10.1016\/j.brainres.2025.149444_b0020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1081\/NCN-200027372","article-title":"Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers","volume":"23","author":"Becker","year":"2004","journal-title":"Nucleosides. Nucleotides Nucleic Acids"},{"key":"10.1016\/j.brainres.2025.149444_b0025","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2025.149444_b0030","first-page":"H563","article-title":"Xanthine oxidase is not a major source of free radicals in focal cerebral ischemia","volume":"260","author":"Betz","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.brainres.2025.149444_b0035","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/0006-2952(77)90171-X","article-title":"Inhibition of human erythrocyte orotidylate decarboxylase","volume":"26","author":"Brown","year":"1977","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2025.149444_b0040","unstructured":"Butterworth, R.F., 1999. Metabolic Encephalopathies, In: Siegel, G. (Ed.), Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 6th Ed., 6th ed. Lippincott-Raven Publishers."},{"key":"10.1016\/j.brainres.2025.149444_b0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cell.2019.12.017","article-title":"FAMIN is a multifunctional purine enzyme enabling the purine nucleotide cycle","volume":"180","author":"Cader","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2025.149444_b0050","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-291X(87)91112-0","article-title":"Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage","volume":"148","author":"Das","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2025.149444_b0055","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1042\/CS20160010","article-title":"Xanthine oxidoreductase and its inhibitors: relevance for gout","volume":"130","author":"Day","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.brainres.2025.149444_b0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0165-0270(95)00119-0","article-title":"Brain regional levels of adenosine and adenosine nucleotides in rats killed by high-energy focused microwave irradiation","volume":"64","author":"Delaney","year":"1996","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainres.2025.149444_b0065","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.2174\/0929867324666170616110111","article-title":"The Role of mitochondrial dysfunction in the progression of alzheimer\u2019s disease","volume":"25","author":"Desler","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.brainres.2025.149444_b0070","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1007\/s11064-020-03124-w","article-title":"Metabolomic and imaging mass spectrometric assays of labile brain metabolites: critical importance of brain harvest procedures","volume":"45","author":"Dienel","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2025.149444_b0075","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1172\/JCI112990","article-title":"Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues","volume":"79","author":"Engerson","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2025.149444_b0080","doi-asserted-by":"crossref","DOI":"10.1177\/2398212817717112","article-title":"Proof of concept and feasibility studies examining the influence of combination ribose, adenine and allopurinol treatment on stroke outcome in the rat","volume":"1","author":"Faller","year":"2017","journal-title":"Brain Neurosci. Adv."},{"key":"10.1016\/j.brainres.2025.149444_b0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11064-017-2386-6","article-title":"The purine salvage pathway and the restoration of cerebral ATP: Implications for brain slice physiology and brain injury","volume":"44","author":"Frenguelli","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2025.149444_b0090","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/S0021-9258(19)43805-2","article-title":"Kinetic properties and inhibition of orotidine 5\u2032-phosphate decarboxylase","volume":"248","author":"Fyfe","year":"1973","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149444_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109370","article-title":"The mammalian purine salvage pathway as an exploitable route for cerebral bioenergetic support after brain injury","volume":"224","author":"Gessner","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2025.149444_b0100","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","article-title":"Reperfusion injury and reactive oxygen species: the evolution of a concept","volume":"6","author":"Granger","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.brainres.2025.149444_b0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0016-5085(81)90648-X","article-title":"Superoxide radicals in feline intestinal ischemia","volume":"81","author":"Granger","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.brainres.2025.149444_b0110","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/bph.14978","article-title":"Perfecting a high hypoxanthine phosphoribosyltransferase activity-uricase KO mice to test the effects of purine- and non-purine-type xanthine dehydrogenase (XDH) inhibitors","volume":"177","author":"Hosoya","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2025.149444_b0115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jnnp.49.5.585","article-title":"An assessment of the possible protective effect of allopurinol in acute stroke","volume":"49","author":"Iansek","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2025.149444_b0120","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.STR.17.6.1284","article-title":"Effect of allopurinol on ischemia and reperfusion-induced cerebral injury in spontaneously hypertensive rats","volume":"17","author":"Itoh","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2025.149444_b0125","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1471-4159.1993.tb03488.x","article-title":"Brain purines in a genetic mouse model of Lesch\u2010Nyhan disease","volume":"60","author":"Jinnah","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2025.149444_b0130","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/RHU.0b013e31821d36cc","article-title":"An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan Ph","volume":"17","author":"Kamatani","year":"2011","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.brainres.2025.149444_b0135","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jnen\/nlw088","article-title":"New strategy that delays progression of amyotrophic lateral sclerosis in G1H-G93A transgenic mice: oral administration of xanthine oxidoreductase inhibitors that are not substrates for the purine salvage pathway","volume":"75","author":"Kato","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.brainres.2025.149444_b0140","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.169.3943.388","article-title":"Allopurinol: alteration in pyrimidine metabolism in man","volume":"169","author":"Kelley","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.brainres.2025.149444_b0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0006-8993(89)91504-7","article-title":"Extracellular increase of hypoxanthine and xanthine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia","volume":"478","author":"Kjellmer","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2025.149444_b0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0014-2999(93)90033-E","article-title":"Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees","volume":"250","author":"Komoriya","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2025.149444_b0155","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1016\/S0021-9258(18)99622-5","article-title":"Ribonucleosides of allopurinol and oxoallopurinol","volume":"242","author":"Krenitsky","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149444_b0160","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/S0021-9258(18)93353-3","article-title":"Inhibition of human purine nucleoside phosphorylase","volume":"243","author":"Krenitsky","year":"1968","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149444_b0165","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0021-9258(18)91838-7","article-title":"Human hypoxanthine phosphoribosyltransferase","volume":"244","author":"Krenitsky","year":"1969","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149444_b0170","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1038\/s41467-019-12565-z","article-title":"Targeted knock-in mice expressing the oxidase-fixed form of xanthine oxidoreductase favor tumor growth","volume":"10","author":"Kusano","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainres.2025.149444_b0175","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nprot.2008.61","article-title":"Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells","volume":"3","author":"Kuznetsov","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.brainres.2025.149444_b0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0305-0491(80)90218-7","article-title":"Adenine and hypoxanthine salvage in erythrocytes of eight mammalian species","volume":"66","author":"Lalanne","year":"1980","journal-title":"Comp. Biochem. Physiol. B: Comp. Biochem."},{"key":"10.1016\/j.brainres.2025.149444_b0185","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuropharm.2010.09.005","article-title":"Neuroprotective effects of resveratrol on ischemic injury mediated by improving brain energy metabolism and alleviating oxidative stress in rats","volume":"60","author":"Li","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2025.149444_b0190","first-page":"967","article-title":"Cellular expression of xanthine oxidoreductase protein in normal human tissues","volume":"79","author":"Linder","year":"1999","journal-title":"Lab. Invest."},{"key":"10.1016\/j.brainres.2025.149444_b0195","first-page":"H2051","article-title":"Role of xanthine dehydrogenase and oxidase in focal cerebral ischemic injury to rat","volume":"261","author":"Lindsay","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.brainres.2025.149444_b0200","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.brainres.2005.11.061","article-title":"Effect of allopurinol on brain adenosine levels during hypoxia in newborn piglets","volume":"1073\u20131074","author":"Marro","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2025.149444_b0205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM198501173120305","article-title":"Oxygen-derived free radicals in postischemic tissue injury","volume":"312","author":"McCord","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2025.149444_b0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1471-4159.1975.tb11868.x","article-title":"The levels of labile intermediary metabolites in mouse brain following rapid tissue fixation with microwave irradiation","volume":"24","author":"Medina","year":"1975","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2025.149444_b0215","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1471-4159.1977.tb12328.x","article-title":"A comparison of methods for stopping intermediary metabolism of developing rat brain","volume":"28","author":"Miller","year":"1977","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2025.149444_b0220","first-page":"H1655","article-title":"No conversion of xanthine dehydrogenase to oxidase in canine cerebral ischemia","volume":"259","author":"Mink","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.brainres.2025.149444_b0225","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.STR.22.5.660","article-title":"Allopurinol pretreatment improves evoked response recovery following global cerebral ischemia in dogs","volume":"22","author":"Mink","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2025.149444_b0230","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.brainres.2007.02.004","article-title":"The effect of infusing hypoxanthine or xanthine on hypoxic-ischemic brain injury in rabbits","volume":"1147","author":"Mink","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2025.149444_b0235","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/biomedicines10071584","article-title":"Analysis of purine metabolism to elucidate the pathogenesis of acute kidney injury in renal hypouricemia","volume":"10","author":"Miyamoto","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.brainres.2025.149444_b0240","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fphar.2016.00518","article-title":"Identification of febuxostat as a new strong ABCG2 inhibitor: potential applications and risks in clinical situations","volume":"7","author":"Miyata","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2025.149444_b0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-5793(87)81458-8","article-title":"Allopurinol and oxypurinol are hydroxyl radical scavengers","volume":"213","author":"Moorhouse","year":"1987","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainres.2025.149444_b0250","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2017.07.024","article-title":"ATP maintenance via two types of ATP regulators mitigates pathological phenotypes in mouse models of Parkinson\u2019s disease","volume":"22","author":"Nakano","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.brainres.2025.149444_b0255","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/0006-2952(73)90082-8","article-title":"Formation of nucleotides of [6-14C]allopurinol and [6-14C]oxipurinol in rat tissues and effects on uridine nucleotide pools","volume":"22","author":"Nelson","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2025.149444_b0260","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1227\/00006123-198910000-00016","article-title":"Cerebral uric acid, xanthine, and hypoxanthine after ischemia: the effect of allopurinol","volume":"25","author":"Nihei","year":"1989","journal-title":"Neurosurgery"},{"key":"10.1016\/j.brainres.2025.149444_b0265","doi-asserted-by":"crossref","unstructured":"Nishida, Y., Kamatani, N., Tanimoto, K., Akaoka, I., 1979. Inhibition of purine nucleoside phosphorylase activity and of T-cell function with allopurinol-riboside. Agents Actions, 9, 549\u2013552. https:\/\/doi.org\/10.1007\/BF01968126.","DOI":"10.1007\/BF01968126"},{"key":"10.1016\/j.brainres.2025.149444_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.jbchem.a124480","article-title":"The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury","volume":"116","author":"Nishino","year":"1994","journal-title":"J. Biochem."},{"key":"10.1016\/j.brainres.2025.149444_b0275","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/HYPERTENSIONAHA.109.135152","article-title":"Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules","volume":"54","author":"Ohtsubo","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.brainres.2025.149444_b0280","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1074\/jbc.M208307200","article-title":"An extremely potent inhibitor of xanthine oxidoreductase","volume":"278","author":"Okamoto","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149444_b0285","doi-asserted-by":"crossref","unstructured":"Okamoto, K., Eger, B.T., Nishino, Tomoko, Pai, E.F., Nishino, Takeshi, 2008. Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol, in: Nucleosides, Nucleotides and Nucleic Acids. https:\/\/doi.org\/10.1080\/15257770802146577.","DOI":"10.1080\/15257770802146577"},{"key":"10.1016\/j.brainres.2025.149444_b0290","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2741\/4521","article-title":"Mitochondria in the pathophysiology of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"22","author":"Onyango","year":"2017","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.brainres.2025.149444_b0295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0014-2999(93)90201-R","article-title":"Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents","volume":"241","author":"Osada","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2025.149444_b0300","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/jcbfm.1990.39","article-title":"Carbohydrate and energy metabolism during the evolution of hypoxic-ischemic brain damage in the immature rat","volume":"10","author":"Palmer","year":"1990","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2025.149444_b0305","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1203\/00006450-199004000-00003","article-title":"Reduction of perinatal hypoxic-ischemic brain damage with allopurinol","volume":"27","author":"Palmer","year":"1990","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.brainres.2025.149444_b0310","first-page":"G768","article-title":"Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation","volume":"254","author":"Parks","year":"1988","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.brainres.2025.149444_b0315","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1046\/j.1471-4159.1995.64052177.x","article-title":"Oxypurinol-enhanced postischemic recovery of the rat brain involves preservation of adenine nucleotides","volume":"64","author":"Phillis","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2025.149444_b0320","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.920643","article-title":"Machine learning for discovery of new ADORA modulators","volume":"13","author":"Puhl","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2025.149444_b0325","first-page":"157","article-title":"Effects of a novel xanthine oxidoreductase inhibitor on increasing ATP in mouse vascular smooth muscle cells and high precision analysis of intracellular purine compounds by HPLC using an internal standard","volume":"47","author":"Sato","year":"2023","journal-title":"Gout and Uric & Nucleic Acids"},{"key":"10.1016\/j.brainres.2025.149444_b0330","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3390\/biomedicines9111723","article-title":"Association of mutations identified in xanthinuria with the function and inhibition mechanism of xanthine oxidoreductase","volume":"9","author":"Sekine","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.brainres.2025.149444_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107524","article-title":"Significance and amplification methods of the purine salvage pathway in human brain cells","volume":"300","author":"Sekine","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149444_b0340","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.3390\/ijms22073542","article-title":"Xanthine oxidoreductase-mediated superoxide production is not involved in the age-related pathologies in sod1-deficient mice","volume":"22","author":"Shibuya","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.149444_b0345","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0009-8981(69)90052-7","article-title":"Urinary excretion of purines, pyrimidines and pyrazolopyrimidines in patients treated with allopurinol or oxipurinol","volume":"23","author":"Simmonds","year":"1969","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.brainres.2025.149444_b0350","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/0006-2952(73)90062-2","article-title":"Metabolic studies of purine metabolism in the pig during the oral administration of guanine and allopurinol","volume":"22","author":"Simmonds","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2025.149444_b0355","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/cs0800191","article-title":"Orotidine accumulation in human erythrocytes during allopurinol therapy: Association with high urinary oxypurinol-7-riboside concentrations in renal failure and in the Lesch-Nyhan syndrome","volume":"80","author":"Simmonds","year":"1991","journal-title":"Clin. Sci."},{"key":"10.1016\/j.brainres.2025.149444_b0360","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1471-4159.1988.tb03006.x","article-title":"Hypoxanthine transport and metabolism in the central nervous system","volume":"50","author":"Spector","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2025.149444_b0365","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/jnc.12026","article-title":"Microwave irradiation decreases ATP, increases free [Mg2+], and alters in vivo intracellular reactions in rat brain","volume":"123","author":"Srivastava","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2025.149444_b0370","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2176\/nmc.oa.2013-0307","article-title":"Evaluation of neuronal protective effects of xanthine oxidoreductase inhibitors on severe whole-brain ischemia in mouse model and analysis of xanthine oxidoreductase activity in the mouse brain","volume":"55","author":"Suzuki","year":"2015","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"10.1016\/j.brainres.2025.149444_b0375","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.lfs.2004.10.031","article-title":"Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase\/xanthine dehydrogenase","volume":"76","author":"Takano","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2025.149444_b0380","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1203\/00006450-199004000-00001","article-title":"Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage","volume":"27","author":"Vannucci","year":"1990","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.brainres.2025.149444_b0385","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1471-4159.1973.tb12115.x","article-title":"Freeze\u2010blowing: a new technique for the study of brain in vivo","volume":"20","author":"Veech","year":"1973","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2025.149444_b0390","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","article-title":"Mitochondrial diseases in man and mouse","volume":"283","author":"Wallace","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.brainres.2025.149444_b0395","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jneumeth.2018.05.016","article-title":"The use of microwave irradiation for quantitative analysis of neurotransmitters in the mouse brain","volume":"307","author":"Wasek","year":"2018","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainres.2025.149444_b0400","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0003-9861(76)90088-6","article-title":"The mechanism of conversion of rat liver xanthine dehydrogenase from an NAD+-dependent form (type D) to an O2-dependent form (type O)","volume":"172","author":"Waud","year":"1976","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.brainres.2025.149444_b0405","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0003-9861(76)90087-4","article-title":"Purification and properties of the NAD+-dependent (type D) and O2-dependent (type O) forms of rat liver xanthine dehydrogenase","volume":"172","author":"Waud","year":"1976","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.brainres.2025.149444_b0410","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/jcbfm.1982.22","article-title":"Columnar alterations of NADH fluorescence during hypoxia-ischemia in immature rat brain","volume":"2","author":"Welsh","year":"1982","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2025.149444_b0415","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3940(92)90726-N","article-title":"Allopurinol preserves cerebral energy metabolism during perinatal hypoxia-ischemia: a 31P NMR study in unanesthetized immature rats","volume":"144","author":"Williams","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2025.149444_b0420","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0304-3940(94)90231-3","article-title":"Cerebral energy metabolism during hypoxia-ischemia correlates with brain damage: a 31P NMR study in unanesthetized immature rats","volume":"170","author":"Williams","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2025.149444_b0425","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbadis.2009.08.013","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"1802","author":"Winklhofer","year":"2010","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.brainres.2025.149444_b0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133980","article-title":"The effects of xanthine oxidoreductase inhibitors on oxidative stress markers following global brain ischemia reperfusion injury in C57BL\/6 mice","volume":"10","author":"Yamaguchi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2025.149444_b0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0173512","article-title":"The renal phenotype of allopurinol-treated HPRT-deficient mouse","volume":"12","author":"Zennaro","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2025.149444_b0440","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s11064-022-03697-8","article-title":"Cell death mechanisms in cerebral ischemia-reperfusion injury","volume":"47","author":"Zhang","year":"2022","journal-title":"Neurochem. Res."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T21:09:32Z","timestamp":1737407372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899325000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":88,"alternative-id":["S0006899325000022"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149444","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A non-purine inhibitor of xanthine oxidoreductase mitigates adenosine triphosphate degradation under hypoxic conditions in mouse brain","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"149444"}}